Amarin | AMRN - Efectivo Y Equivalentes

Precio De Mercado
14.49
Cambio Diario
-0.51 -3.40%
Mensual
-7.29%
Anual
58.50%
Q1 Expectativa
14.05




Efectivo Y Equivalentes Cambio Fecha
AbbVie USD 5.23B 400M 2025-12
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Amarin USD 122.8M 25.08M 2025-09
AstraZeneca USD 8.14B 1.08B 2025-09
BioCryst Pharmaceuticals USD 335.91M 251.83M 2025-12
DBV Technologies USD 69.84M 33.37M 2025-09
Esperion Therapeutics USD 92.45M 6.39M 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Halozyme Therapeutics USD 133.82M 285.84M 2025-12
Heron Therapeutics USD 43.07M 26.55M 2025-09
Ionis Pharmaceuticals USD 2.68B 437M 2025-12
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Neurocrine Biosciences USD 713M 372.8M 2025-12
Novartis USD 9.56B 2.9B 2025-09